This is a pediatric kidney transplant study comparing the safety and efficacy of an
immunosuppressive regimen of belatacept and sirolimus to tacrolimus and Mycophenolate Mofetil
(MMF). Two hundred participants will be randomized (1:1) to one of two groups within 24 hours
following the transplant procedure. The duration of the study from time of transplant to the
primary endpoint is 12-24 months.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)